What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
His primary scientific interests are in COPD, Internal medicine, Surgery, Intensive care medicine and Randomized controlled trial.
His COPD research is multidisciplinary, incorporating perspectives in Exacerbation, Physical therapy, Lung and Pulmonary function testing.
His research in Internal medicine intersects with topics in Gastroenterology, Placebo and Cardiology.
His Surgery study combines topics in areas such as Respiratory disease, Quality of life, Endobronchial valve and Lung volume reduction surgery.
The various areas that Gerard J. Criner examines in his Intensive care medicine study include Pulmonary disease, Guideline, Disease and Psychological intervention.
His Randomized controlled trial study combines topics from a wide range of disciplines, such as Clinical trial, Pulmonary rehabilitation and Hazard ratio, Confidence interval.
His most cited work include:
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary (1253 citations)
- Azithromycin for Prevention of Exacerbations of COPD (806 citations)
- Chronic obstructive pulmonary disease phenotypes: the future of COPD. (752 citations)
What are the main themes of his work throughout his whole career to date?
Gerard J. Criner mainly focuses on COPD, Internal medicine, Intensive care medicine, Cardiology and Surgery.
The COPD study which covers Spirometry that intersects with FEV1/FVC ratio.
When carried out as part of a general Internal medicine research project, his work on Lung, Cohort and Fluticasone propionate is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
In his work, Respiratory failure is strongly intertwined with Mechanical ventilation, which is a subfield of Intensive care medicine.
His Surgery research incorporates elements of Respiratory disease, Anesthesia and Lung volume reduction surgery.
His study in Lung volume reduction surgery is interdisciplinary in nature, drawing from both Pulmonary function testing and Pneumonectomy.
He most often published in these fields:
- COPD (45.75%)
- Internal medicine (45.33%)
- Intensive care medicine (17.56%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (45.33%)
- COPD (45.75%)
- Pneumonia (3.82%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, COPD, Pneumonia, Exacerbation and In patient.
His Internal medicine study frequently links to related topics such as Gastroenterology.
His COPD research integrates issues from Spirometry, Clinical trial, Intensive care medicine and Fluticasone propionate.
His Pneumonia study which covers Mechanical ventilation that intersects with Respiratory failure.
His Exacerbation research is multidisciplinary, incorporating perspectives in Rate ratio, Quality of life and Lung function.
Gerard J. Criner combines subjects such as Disease progression, Lung volume reduction surgery and Cardiology with his study of Pulmonary disease.
Between 2019 and 2021, his most popular works were:
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. (282 citations)
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. (156 citations)
- Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline (48 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Gerard J. Criner mostly deals with Internal medicine, COPD, Pneumonia, Exacerbation and Intensive care medicine.
His work on Cohort, Pulmonary disease, Clinical endpoint and Hazard ratio as part of general Internal medicine study is frequently linked to In patient, therefore connecting diverse disciplines of science.
His COPD study combines topics in areas such as Clinical trial, Fluticasone propionate, Gastroenterology and Lung, Lung function.
His Pneumonia research includes themes of Tocilizumab, Mechanical ventilation and Incidence.
The Mechanical ventilation study combines topics in areas such as Retrospective cohort study and Respiratory failure.
His research is interdisciplinary, bridging the disciplines of Protocol and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
